2006 Conference Publication Positive margin rates in patients with a single positive core on extended TRUS biopsyDangerfield, D., Samaratunga, H. and Yaxley, J. (2006). Positive margin rates in patients with a single positive core on extended TRUS biopsy. The Urological Society of Australasia Annual Scientific Meeting 2006, Brisbane, QLD Australia, 26-30 March 2006. Chichester, West Sussex United Kingdom: Wiley-Blackwell. |
2006 Conference Publication The significance of finding a small focus of prostatic adenocarcinoma on needle biopsySamaratunga, H, Yaxley, J, Kerr, K and McClymont, K (2006). The significance of finding a small focus of prostatic adenocarcinoma on needle biopsy. 95th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology, Atlanta, Georgia, 11-17 February 2006 . London, United Kingdom: Nature Publishing Group. |
2006 Journal Article A working group classification of focal prostate atrophy lesionsDe Marzo A.M., Platz E.A., Epstein J.I., Ali T., Billis A., Chan T.Y., Cheng L., Datta M., Egevad L., Ertoy-Baydar D., Farree X., Fine S.W., Iczkowski K.A., Ittmann M., Knudsen B.S., Loda M., Lopez-Beltran A., Magi-Galluzzi C., Mikuz G., Montironi R., Pikarsky E., Pizov G., Rubin M.A., Samaratunga H., Sebo T., Sesterhenn I.A., Shah R.B., Signoretti S., Simko J. ... Lucia M.S. (2006). A working group classification of focal prostate atrophy lesions. American Journal of Surgical Pathology, 30 (10), 1281-1291. doi: 10.1097/01.pas.0000213289.50660.be |
2005 Journal Article Compartmentalized expression of kallikrein 4 (KLK4/hK4) isoforms in prostate cancer: nuclear, cytoplasmic and secreted formsDong, Y., Bui, L. T., Odorico, D. M., Tan, O. L., Myers, S. A., Samaratunga, H., Gardiner, R. A. and Clements, J. A. (2005). Compartmentalized expression of kallikrein 4 (KLK4/hK4) isoforms in prostate cancer: nuclear, cytoplasmic and secreted forms. Endocrine-Related Cancer, 12 (4), 875-889. doi: 10.1677/erc.1.01062 |
2005 Journal Article Significance of stromal reaction patterns in invasive urothelial carcinomaSamaratunga, H, Fairweather, P and Purdie, D (2005). Significance of stromal reaction patterns in invasive urothelial carcinoma. American Journal of Clinical Pathology, 123 (6), 851-857. doi: 10.1309/EE8RTB6X611G6TU |
2005 Journal Article Use of multiple biomarkers for a molecular diagnosis of prostate cancerLanders, Kelly A., Burger, Michelle J., Tebay, Michelle A., Purdie, David M., Scells, Betty, Samaratunga, Hemamali, Lavin, Martin F. and Gardiner, Robert A. (2005). Use of multiple biomarkers for a molecular diagnosis of prostate cancer. International Journal of Cancer, 114 (6), 950-956. doi: 10.1002/ijc.20760 |
2005 Conference Publication Claudin 4: a new therapeutic target for prostate cancer?Gardiner, RA, Landers, KA, Burger, MJ, Scells, B, Samaratunga, MLTH and Lavin, MF (2005). Claudin 4: a new therapeutic target for prostate cancer?. Annual Scientific Meeting of the Urological- Society-of-Australasia, Melbourne Australia, Feb 13-17, 2005. OXFORD: BLACKWELL PUBLISHING. |
2005 Conference Publication Prostatic adenocarcinoma with mucinous components a clinicopathological and immunohistochemical studySamaratunga, H. and Brown, I. (2005). Prostatic adenocarcinoma with mucinous components a clinicopathological and immunohistochemical study. 94th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology, San Antonio, TX, United States, 26 February - 4 March 2005. Amsterdam, Netherlands: Elsevier. |
2004 Journal Article Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical studySamaratunga, H and Khoo, K (2004). Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study. Histopathology, 45 (1), 55-64. doi: 10.1111/j.1365-2559.2004.01895.x |
2004 Journal Article Expression of the disintegrin metalloprotease, ADAM-10, in prostate cancer and its regulation by dihydrotestosterone, insulin-like growth factor I, and epidermal growth factor in the prostate cancer cell model LNCaPMcCulloch, Daniel R, Akl, Pascal, Samaratunga, Hemamali, Herington, Adrian C. and Odorico, Dimitri M. (2004). Expression of the disintegrin metalloprotease, ADAM-10, in prostate cancer and its regulation by dihydrotestosterone, insulin-like growth factor I, and epidermal growth factor in the prostate cancer cell model LNCaP. Clinical Cancer Research, 10 (1), 314-323. doi: 10.1158/1078-0432.CCR-0846-3 |
2003 Conference Publication Micropapillary variant of urothelial carcinoma of the urinary bladder: Clinicopathological and immunohistochemical studySamaratunga, H and Khoo, K (2003). Micropapillary variant of urothelial carcinoma of the urinary bladder: Clinicopathological and immunohistochemical study. 92nd Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology, Washington D.C., Mar 22-28, 2003. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. |
2002 Conference Publication Comparison of WHO/ISUP and WHO classification of non-invasive papillary urothelial neoplasms (PTa) for risk of progression.Epstein, JI, Markov, DV and Samaratunga, H (2002). Comparison of WHO/ISUP and WHO classification of non-invasive papillary urothelial neoplasms (PTa) for risk of progression.. 97th Annual Meeting of the American-Urological-Association, Orlando Florida, May 25-30, 2002. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. |
2002 Journal Article Expression analysis of delta-catenin and prostate-specific membrane antigen: Their potential as diagnostic markers for prostate cancerBurger, M. J., Tebay, M. A., Keith, P. A., Samaratunga, H. M., Clements, J. A., Lavin, M. F. and Gardiner, R. A. (2002). Expression analysis of delta-catenin and prostate-specific membrane antigen: Their potential as diagnostic markers for prostate cancer. International Journal of Cancer, 100 (2), 228-237. doi: 10.1002/ijc.10468 |
2002 Journal Article Comparison of WHO/ISUP and WHO classification of noninvasive papillary urothelial neoplasms for risk of progressionSamaratunga H., Makarov D.V. and Epstein J.I. (2002). Comparison of WHO/ISUP and WHO classification of noninvasive papillary urothelial neoplasms for risk of progression. Urology, 60 (2), 315-319. doi: 10.1016/S0090-4295(02)01705-3 |
2001 Journal Article Atypical presentation of herpes simplex (chronic hypertrophic herpes) in a patient with HIV infectionSamaratunga, H, Weedon, D, Musgrave, N and Mccallum, N (2001). Atypical presentation of herpes simplex (chronic hypertrophic herpes) in a patient with HIV infection. Pathology, 33 (4), 532-535. doi: 10.1080/00313020120083322 |
2001 Journal Article Phyllodes tumors of the breast: Correlation of nucleolar organizer regions with histopathological malignancy grading, flow cytometric DNA analysis and clinical outcomeSamaratunga, Hemamali, Clarke, Belinda, Owen, Leigh, Bryson, Greg and Swanson, Cheryl (2001). Phyllodes tumors of the breast: Correlation of nucleolar organizer regions with histopathological malignancy grading, flow cytometric DNA analysis and clinical outcome. Pathology International, 51 (11), 866-873. doi: 10.1046/j.1440-1827.2001.01294.x |
2001 Journal Article Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomasDong, Y, Kaushal, A, Bui, L, Chu, S, Fuller, PJ, Nicklin, J, Samaratunga, H and Clements, JA (2001). Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas. Clinical Cancer Research, 7 (8), 2363-2371. |
1999 Journal Article Cervical adenoid basal epitheliomasSamaratunga, H (1999). Cervical adenoid basal epitheliomas. American Journal of Surgical Pathology, 23 (10), 1308-1309. doi: 10.1097/00000478-199910000-00021 |
1999 Conference Publication Upper Tract Replacement by Bladder with renal Autotransplantation and DexonGardiner, R. A., Teng, H., Hardie, I. R. and Samaratunga, M.L. (1999). Upper Tract Replacement by Bladder with renal Autotransplantation and Dexon. 51st Annual Scientific meeting of the Urological Society of a, Adelaide, March 1998. Asia: Blackwell Science. |
1999 Conference Publication Putative cancer specific variants of PSA and the related kallikreins, K1, K2 are also expressed in Benign prostatic hyperplasiaClements, J. A., Flanagan, J., Samaratunga, M. and Gardiner, R. A. (1999). Putative cancer specific variants of PSA and the related kallikreins, K1, K2 are also expressed in Benign prostatic hyperplasia. 51st Annual Scientific meeting of the Urological Societyof Aa, Adelaide, March 1998. Asia: Blackwell Science. |